Casdin Capital as of Dec. 31, 2016
Portfolio Holdings for Casdin Capital
Casdin Capital holds 25 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sage Therapeutics (SAGE) | 10.9 | $13M | 260k | 51.06 | |
| Loxo Oncology | 9.6 | $12M | 360k | 32.11 | |
| Agios Pharmaceuticals (AGIO) | 8.3 | $10M | 241k | 41.73 | |
| Foundation Medicine | 8.0 | $9.7M | 546k | 17.70 | |
| Evolent Health (EVH) | 6.8 | $8.2M | 555k | 14.80 | |
| Blueprint Medicines (BPMC) | 5.7 | $6.9M | 245k | 28.05 | |
| Spark Therapeutics | 5.3 | $6.4M | 129k | 49.90 | |
| GenMark Diagnostics | 5.2 | $6.2M | 510k | 12.24 | |
| Bluebird Bio (BLUE) | 4.2 | $5.1M | 83k | 61.70 | |
| Voyager Therapeutics (VYGR) | 4.0 | $4.9M | 385k | 12.74 | |
| Global Blood Therapeutics In | 3.6 | $4.4M | 304k | 14.45 | |
| Kite Pharma | 3.5 | $4.2M | 94k | 44.84 | |
| Myokardia | 2.8 | $3.4M | 265k | 12.95 | |
| Epizyme | 2.8 | $3.3M | 275k | 12.10 | |
| Illumina (ILMN) | 2.6 | $3.2M | 25k | 128.04 | |
| Alnylam Pharmaceuticals (ALNY) | 2.6 | $3.2M | 85k | 37.44 | |
| Cerner Corporation | 2.5 | $3.1M | 65k | 47.37 | |
| Allscripts Healthcare Solutions (MDRX) | 2.4 | $2.9M | 280k | 10.21 | |
| Amyris | 2.1 | $2.5M | 3.4M | 0.73 | |
| Syros Pharmaceuticals | 1.8 | $2.2M | 182k | 12.16 | |
| Aevi Genomic | 1.6 | $1.9M | 375k | 5.18 | |
| Cytomx Therapeutics (CTMX) | 1.2 | $1.4M | 128k | 10.99 | |
| Acceleron Pharma | 0.9 | $1.1M | 45k | 25.51 | |
| Editas Medicine (EDIT) | 0.9 | $1.1M | 65k | 16.23 | |
| Gilead Sciences (GILD) | 0.7 | $895k | 13k | 71.60 |
